Thank you InSilicoMinds for showcasing our ๐๐ฟ๐๐ด ๐ฆ๐ฎ๐ณ๐ฒ๐๐ ๐ฆ๐๐ถ๐๐ฒ. Available on InSilicoTrials' cloud-based platform, the suite features 3๏ธโฃtools designed to detect early proarrhythmic risks in #nonclinical development: โ QT/TdP Risk Screen โ CiPA In Silico โ STrhiPS By simulating the impact of #drugcandidates on human cardiomyocytes and stem cell-derived cardiomyocytes, it follows CiPA guidelines and helps #pharmaceutical companies and CROs significantly cut time and costs in #drugdevelopment.
๐๐ง๐ญ๐ซ๐จ๐๐ฎ๐๐ข๐ง๐ ๐ญ๐ก๐ ๐๐ซ๐ฎ๐ ๐๐๐๐๐ญ๐ฒ ๐๐ฎ๐ข๐ญ๐: ๐๐๐ฏ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ข๐ณ๐ข๐ง๐ ๐๐๐ซ๐๐ข๐๐ ๐๐ข๐ฌ๐ค ๐๐ฌ๐ฌ๐๐ฌ๐ฌ๐ฆ๐๐ง๐ญ๐ซ๐ป In an era where regulatory bodies are enhancing the assessment of drug-induced proarrhythmic risks, the ๐๐ฟ๐๐ด ๐ฆ๐ฎ๐ณ๐ฒ๐๐ ๐ฆ๐๐ถ๐๐ฒ emerges as a game-changer. Developed by our exclusive partner InSilicoTrials, a leading provider of in silico solutions, and offers cutting-edge computational tools and solutions to accelerate #drugdiscovery and #development. ๐ The Drug Safety Suite includes the innovative ๐๐ผ๐บ๐ฝ๐ฟ๐ฒ๐ต๐ฒ๐ป๐๐ถ๐๐ฒ ๐๐ป ๐ฉ๐ถ๐๐ฟ๐ผ ๐ฃ๐ฟ๐ผ๐ฎ๐ฟ๐ฟ๐ต๐๐๐ต๐บ๐ถ๐ฎ ๐๐๐๐ฎ๐ (๐๐ถ๐ฃ๐) ๐๐ป๐ฆ๐ถ๐น๐ถ๐ฐ๐ผ initiative to increase early detection of cardiac safety liabilities. ๐ฆ๐ง๐ต๐ฟ๐ถ๐ฃ๐ helps to identify drug compound #safety windows, guiding in vitro and in vivo testing to reduce #risks and #investments.ย ๐ค๐ง/๐ง๐ฑ๐ฃ ๐ฅ๐ถ๐๐ธ ๐ฆ๐ฐ๐ฟ๐ฒ๐ฒ๐ป evaluates clinical risks using CredibleMeds classification, ensuring comprehensive safety assessments across various #drug concentrations. By incorporating advanced #modelingandsimulation, it provides a unified, #cloud-based platform designed for ease of use, ensuring rigorous evaluation without the need for extensive IT investments. โฌ ๐ฐ ๐๐ ๐ฝ๐ฒ๐ฟ๐ถ๐ฒ๐ป๐ฐ๐ฒ ๐๐ต๐ฒ ๐๐๐๐๐ฟ๐ฒ ๐ผ๐ณ ๐๐ฟ๐๐ด ๐ฆ๐ฎ๐ณ๐ฒ๐๐ ๐ง๐ฒ๐๐๐ถ๐ป๐ด ๐ง๐ผ๐ฑ๐ฎ๐ With its robust, #cybersecure infrastructure and pay-per-use model, the Drug Safety Suite is built to support the latest in #regulatory guidelines and scientific #research. This results in a drastic reduction in R&D #timelines and #costs, allowing for early disqualification of unsafe #molecules and more accurate decision-making. โจ Don't miss the opportunity to #enhance your drug development processโ request a demo and a free test today to see how the Drug Safety Suite can #revolutionize your cardiac safety assessments. #DrugSafety #CardiacSafety #InSilico #CiPA #R&DInnovation #Pharmaceuticals #ClinicalResearch #RegulatoryCompliance #DrugDevelopment #SimulationTechnology #CloudSolutionsย
